Home › Funds › Performa Ltd (US), LLC › VTGN
Performa Ltd (US), LLC position in VTGN
VISTAGEN THERAPEUTICS INC · Health Care
Performa Ltd (US), LLC reported holding 10,750 shares of VTGN (VISTAGEN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3K, representing 0.00% of its reported portfolio and ranking #46 among its reported holdings. Performa Ltd (US), LLC has disclosed VTGN holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Performa Ltd (US), LLC's VTGN position evolved
Performa Ltd (US), LLC first disclosed a stake in VTGN in Q4 2024 at 1,000 shares (US$3K). The position peaked in Q1 2026 at 7,500 shares, worth US$4K. Across 8 filings, Performa Ltd (US), LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 10,750 shares valued at US$3K — an increase of 5,250 shares quarter over quarter.. Notable position changes include a 650% increase in Q1 2026 (shares fell 60% over the following quarter), a 27% trim in Q2 2026 (shares rose 35% over the following quarter), a 95% increase in Q3 2026 (shares fell 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.00K | $2.95K | New |
| Q1 2025 | 1.00K | $2.50K | Hold |
| Q2 2025 | 1.00K | $2.00K | Hold |
| Q3 2025 | 1.00K | $3.55K | Hold |
| Q4 2025 | 1.00K | $662 | Hold |
| Q1 2026 | 7.50K | $4.29K | Add |
| Q2 2026 | 5.50K | $1.24K | Reduce |
| Q3 2026 | 10.75K | $3.31K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VTGN and 13F data
VTGN (VISTAGEN THERAPEUTICS INC) is a Health Care company. 10 other funds we track also report a position in VTGN — the largest reported positions include Commodore Capital LP (US$630K), LUMINUS MANAGEMENT LLC (US$91K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VTGN
- Commodore Capital LP 2.79M sh · $630.23K · Q2 2026
- LUMINUS MANAGEMENT LLC 403.12K sh · $91.10K · Q2 2026
More on Performa Ltd (US), LLC
FAQ
How long has Performa Ltd (US), LLC held VTGN?
Performa Ltd (US), LLC has disclosed VTGN holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Performa Ltd (US), LLC's current position in VTGN?
As of Q3 2026, Performa Ltd (US), LLC holds 10.75K shares of VTGN (VISTAGEN THERAPEUTICS INC), valued at $3.31K, representing 0.00% of its reported portfolio and ranking #46.
Has Performa Ltd (US), LLC been buying or selling VTGN?
In the latest 13F filing (Q3 2026), Performa Ltd (US), LLC increased its position in VTGN. The position peaked in Q1 2026 at 7.50K shares.
Which other funds hold VTGN?
Other major institutional holders of VTGN include Commodore Capital LP, LUMINUS MANAGEMENT LLC, among 10 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.